Article: Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment.
Therapeutic advances in neurological disorders
2021 Volume 14, Page(s) 1756286421990500
Language | English |
---|---|
Publishing date | 2021-02-01 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2442245-9 |
ISSN | 1756-2864 ; 1756-2856 |
ISSN (online) | 1756-2864 |
ISSN | 1756-2856 |
DOI | 10.1177/1756286421990500 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.